Recent public signals classified as Mass Contract, with first-party permanent pages for source and price-impact review.
SLB announced a 15-year agreement with TotalEnergies to deploy DrillPlan for coherent well planning and engineering, linking subsurface data with execution workflows. The collaboration underscores a broader shift to digital planning in upstream operations and could expand SLB's software backlog and recurring revenue as adoption scales.
View signal analysisTechnipFMC has secured a significant Petrobras subsea contract to design, engineer, and manufacture flexible flowlines for multiple pre-salt fields offshore Brazil. The win highlights ongoing Brazilian offshore capex and expands FTI's regional backlog and local footprint. If confirmed, the order could improve near-term revenue visibility and set the stage for further Brazil subsea awards.
View signal analysisVoyager Technologies announced a $22.4 million Other Transaction Agreement with the DoD's Strategic Capabilities Office to prototype next-generation satellite deployment systems, aiming to transfer the technology to the U.S. Space Force. The award validates Voyager's rapid R&D capabilities and could unlock longer-term defense programs, though OTA funding is not guaranteed revenue and remains contingent on future awards.
View signal analysisGilat’s Peru subsidiary won a $28 million contract from Pronatel to upgrade broadband in Ica, delivering 20x faster speeds to 116 public institutions and free Wi‑Fi in 30 squares. Construction should finish by mid-2027, followed by a seven-year operational phase, expanding Gilat’s international backlog and government-facing footprint in Peru.
View signal analysisBWX Technologies has been awarded a roughly $189 million contract to manufacture naval reactor fuel through its Nuclear Fuel Services unit in Erwin, Tennessee. The work supports the U.S. Naval Nuclear Propulsion Program and powers multiple submarines, including Ohio, Virginia, Seawolf, Los Angeles, and Columbia-class. The award enhances BWXT's naval fuel backlog and provides near-term revenue visibility.
View signal analysisNRXP’s NRXD subsidiary won a DARPA contract worth $11.18 million to run the SPARC-TMS trial, pairing a one-day robotic TMS session with NRX-101. If SPARC-TMS replicates prior 91% response and 69% remission in 3 months, it could become an FDA registration study for NRX-101 with TMS, expanding addressable CNS markets. Partnerships with HOPE Therapeutics, McLean Hospital, ASU, and others could accelerate deployment in military settings.
View signal analysis